Back
Blackrock Debt Strategies Fund Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
54
DSU
Blackrock Debt Strategies Fund
Last Price:
11.04
Seasonality Move:
-1.86%
Sell
36
SRPT
Sarepta Therapeutics
Last Price:
124.65
Seasonality Move:
-1.39%
Buy
54
Blackrock Debt Strategies Fund (DSU)
is a Buy
Is Blackrock Debt Strategies Fund a Buy, Sell or Hold?
- The current Blackrock Debt Strategies Fund [DSU] share price is $11.05. The Score for DSU is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- DSU is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DSU Stock Price Chart
What is Blackrock Debt Strategies Fund's stock price today?
-
The Blackrock Debt Strategies Fund share price today is $11.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSU is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $124.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
DSU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 57.72 | Buy |
Chaikin Money Flow: | 109569 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.87 - 11.03) | Buy |
Bollinger Bands (100): | (10.83 - 10.99) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.18 | Sell |
Relative Strength Index (14 RSI): | 35.54 | Sell |
Chaikin Money Flow: | -49995 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (124.27 - 135.95) | Sell |
Bollinger Bands (100): | (123.89 - 147.49) | Sell |
DSU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11 | Buy |
20-day SMA: | 10.98 | Buy |
50-day SMA: | 10.9 | Buy |
200-day SMA: | 10.91 | Buy |
8-day EMA: | 11 | Buy |
20-day EMA: | 10.97 | Buy |
50-day EMA: | 10.93 | Buy |
200-day EMA: | 10.78 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 125.45 | Sell |
20-day SMA: | 127.75 | Sell |
50-day SMA: | 135.2 | Sell |
200-day SMA: | 127.53 | Sell |
8-day EMA: | 125.39 | Sell |
20-day EMA: | 128.04 | Sell |
50-day EMA: | 132.59 | Sell |
200-day EMA: | 128.64 | Sell |
Blackrock Debt Strategies Fund Earnings Growth & DSU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.
Blackrock Debt Strategies Fund Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |